Bottom line
AHSAX vs QAAGZX: the short answer
AHSAX (Alger Health Sciences Fund) and QAAGZX (T. Rowe Price Health Sciences Portfolio) are both mutual funds.
But QAAGZX is far broader, holding 277 positions to 55 for AHSAX, so beyond the top names it adds exposure AHSAX doesn't have.
QAAGZX is cheaper at 0.86% vs 1.17% — a difference of $31 a year per $10,000 invested.
Over five years, QAAGZX returned +4.1% a year vs −3.0% for AHSAX.
AHSAX has a front-end sales load of up to 5.25%; the other does not.
Updated Nov 19, 2026
AHSAX vs QAAGZX side by side
| AHSAX | QAAGZX | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Alger | T. Rowe Price |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.17% | 0.86% |
| Annual cost per $10k | $117 | $86 |
| 10-yr cost on $10k (prospectus) | $1,871 | $1,061 |
| Max front load | 5.25% | None |
| 12b-1 fee | 0.25% | 0% |
| 1-yr return | +4.4% | +18.1% |
| 5-yr return (annualized) | −3.0% | +4.1% |
| 10-yr return (annualized) | +6.8% | +9.0% |
| Best quarter | +24.5% | +23.4% |
| Worst quarter | −18.7% | −15.8% |
| Net assets (fund) | $75.4M | $751.7M |
| Number of holdings | 55 | 277 |
| Portfolio turnover | 289% | 65% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | AHSAX | QAAGZX | Difference |
|---|---|---|---|
| 2025 | +10.2% | +18.1% | −7.9% |
| 2024 | +1.2% | +1.7% | −0.5% |
| 2023 | −4.3% | +3.0% | −7.2% |
| 2022 | −17.0% | −12.5% | −4.6% |
| 2021 | +2.5% | +13.1% | −10.6% |
| 2020 | +31.0% | +29.6% | +1.4% |
| 2019 | +22.0% | +29.0% | −6.9% |
| 2018 | +5.8% | +1.1% | +4.7% |
| 2017 | +37.2% | +27.6% | +9.6% |
| 2016 | −3.3% | −10.5% | +7.2% |
Source: Fund prospectus bar charts
Holdings overlap
9 of AHSAX's top 25 holdings also appear in QAAGZX's top 25.
| Holding | AHSAX | QAAGZX |
|---|---|---|
| Merck & Company Inc | 4.18% | 4.00% |
| Johnson & Johnson | 4.06% | 6.64% |
| Thermo Fisher Scientific Inc | 4.00% | 2.53% |
| Cvs Health Corp | 3.67% | 0.93% |
| Unitedhealth Group Inc | 3.61% | 5.88% |
| Eli Lilly & Company | 3.29% | 14.06% |
| Abbott Laboratories | 2.93% | 1.91% |
| Guardant Health Inc | 1.81% | 1.22% |
| Vertex Pharmaceuticals Inc | 1.80% | 2.26% |
Source: SEC Form N-PORT
AHSAX top 10
- Dreyfus Treasury Obligations Cash Management — 6.51%
- Impulse Dynamics Ireland — 4.27%
- Merck & Company Inc — 4.18%
- Welltower Inc — 4.12%
- Johnson & Johnson — 4.06%
- Thermo Fisher Scientific Inc — 4.00%
- Bruker Corp — 3.98%
- Illumina Inc — 3.95%
- Cvs Health Corp — 3.67%
- Unitedhealth Group Inc — 3.61%
QAAGZX top 10
- Eli Lilly & Co — 14.06%
- Johnson & Johnson — 6.64%
- Unitedhealth Group Inc — 5.88%
- Abbvie Inc — 5.12%
- Merck & Co. Inc. — 4.00%
- Gilead Sciences Inc — 2.79%
- Thermo Fisher Scientific Inc — 2.53%
- Vertex Pharmaceuticals Inc — 2.26%
- Bristol-myers Squibb Co — 2.12%
- Abbott Laboratories — 1.91%
FAQ
What is the difference between AHSAX and QAAGZX?
Which is cheaper, AHSAX or QAAGZX?
Should I own both AHSAX and QAAGZX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.